Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.61 +0.15 (+4.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (EOCN) Price to Sales (2017 - 2019)

Updated

Galmed Pharmaceuticals' Price to Sales came in at 87.29 for Q2 2019, down 44.9% from 158.33 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Price to Sales (2017 - 2019) Analysis & Trends

For FY2018, Galmed Pharmaceuticals' Price to Sales was 70.44, down 42.1% from FY2017.

  • Going back by year, Price to Sales was 121.74 in FY2017 (+33.3%) and 91.31 in FY2016.
  • The five-year range for quarterly Price to Sales is 70.44 (Q4 2018) to 158.33 (Q2 2018).
  • Year-over-year, Price to Sales increased in 1 of the last five quarters, with an average decline of 0.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Galmed Pharmaceuticals 420,034.32 420,034.32 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 87.29
Dec 31, 2018 70.44
Sep 30, 2018 84.79
Jun 30, 2018 158.33
Mar 31, 2018 74.11
Dec 31, 2017 121.74
Sep 30, 2017 102.35
Jun 30, 2017 74.96
Mar 31, 2017 80.83
API Access

Galmed Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=EOCN&period=max&api_key=YOUR_API_KEY